AU2002357729A8 - Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases - Google Patents

Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases

Info

Publication number
AU2002357729A8
AU2002357729A8 AU2002357729A AU2002357729A AU2002357729A8 AU 2002357729 A8 AU2002357729 A8 AU 2002357729A8 AU 2002357729 A AU2002357729 A AU 2002357729A AU 2002357729 A AU2002357729 A AU 2002357729A AU 2002357729 A8 AU2002357729 A8 AU 2002357729A8
Authority
AU
Australia
Prior art keywords
cis
trans
diseases
treatment
linoleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357729A
Other versions
AU2002357729A1 (en
Inventor
Vijaya Juturu
Danielle Greenberg
James R Komorowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutrition 21 LLC
Original Assignee
Nutrition 21 LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 LLC filed Critical Nutrition 21 LLC
Publication of AU2002357729A8 publication Critical patent/AU2002357729A8/en
Publication of AU2002357729A1 publication Critical patent/AU2002357729A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
AU2002357729A 2001-11-16 2002-11-12 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases Abandoned AU2002357729A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33249601P 2001-11-16 2001-11-16
US60/332,496 2001-11-16
PCT/US2002/036684 WO2003043569A2 (en) 2001-11-16 2002-11-12 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases

Publications (2)

Publication Number Publication Date
AU2002357729A8 true AU2002357729A8 (en) 2003-06-10
AU2002357729A1 AU2002357729A1 (en) 2003-06-10

Family

ID=23298480

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357729A Abandoned AU2002357729A1 (en) 2001-11-16 2002-11-12 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases

Country Status (2)

Country Link
AU (1) AU2002357729A1 (en)
WO (1) WO2003043569A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2134351B1 (en) 2007-03-13 2016-04-27 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2396082B1 (en) 2009-02-16 2013-07-31 Nogra Pharma Limited Methods for treating hair related conditions
CN105749253A (en) 2011-03-01 2016-07-13 Jds治疗有限公司 Methods And Compositions For The Treatment And Prevention Of Hypoglycemia And Related Disorders
EA030762B1 (en) 2012-02-09 2018-09-28 Ногра Фарма Лимитед Methods of treating fibrosis
EP3413900A1 (en) 2016-02-11 2018-12-19 Nutrition 21, LLC Chromium containing compositions for improving health and fitness
EP3419616A1 (en) * 2016-02-26 2019-01-02 Nogra Pharma Limited Methods of treating lactose intolerance
KR20210125047A (en) 2019-02-08 2021-10-15 노그라 파마 리미티드 Process for the preparation of 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN115245510A (en) * 2021-04-28 2022-10-28 扬州大学 Application of trans-10, cis-12 conjugated linoleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948772A (en) * 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof

Also Published As

Publication number Publication date
WO2003043569A2 (en) 2003-05-30
AU2002357729A1 (en) 2003-06-10
WO2003043569A3 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
MXPA03002814A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
NO20043000L (en) A preparation for the treatment of neurocerebrovascular diseases
ZA200306234B (en) Phenethanolamine derivatives for treatment of respiratory diseases.
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
MXPA03007087A (en) Process for the manufacture of phenylacetic acid derivatives.
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002357729A8 (en) Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
FI20020593A (en) Process for the preparation of conjugated linoleic acid
AU2003222837A1 (en) Method for producing conjugated linoleic acid glycerides
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
MXPA03004017A (en) Method for the treatment of inflammation.
AU2003294916A1 (en) Use of cis-99, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
FI19992477A (en) Process for the preparation of conjugated linoleic acid
IL172377A0 (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
AU2002314594A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
SG107315A1 (en) Use of conjugated linoleic acid derivatives
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
EP1426762A4 (en) Remedies for heart diseases
AU2002357964A1 (en) Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase